Mpox Viral Clearance, Transmission, and Vaccine Effectiveness Study
Part of Infections clinical trials.
This study in West Africa follows people with confirmed mpox (monkeypox) infection and their close contacts to understand how the virus spreads, clears from the body, and how well the mpox vaccine protects people. You may be eligible if you've recently tested positive for mpox, were exposed to someone with mpox, or live in an area offering mpox vaccination.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You tested positive for mpox by PCR (a laboratory test that detects the virus), or you had close physical contact with someone who did within 14 days of their symptom start
- If you have mpox: symptoms started within the last 10 days
- You can attend follow-up visits in person for up to 2 months
- You can provide written consent (or a legal representative can consent for you if you're under 18 or unable to consent yourself)
- You do not require hospitalization for severe mpox
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how mpox affects people, how it spreads, and what happens over time. If you are being tested for mpox, you may join to help researchers learn more.
This observational study looks at how your body’s defenses work against mpox (monkeypox), based on blood and health information. You may be eligible if you recently got an mpox vaccine or have had mpox infection and are now out of isolation.
This study is looking at people with mpox in the DR Congo to learn more about the outbreak. If you have a rash that fits the mpox pattern and a positive lab test, you may be able to join.
This trial tests a new mRNA vaccine to prevent mpox. It looks at how safe and effective the vaccine is in adults who have or haven't been exposed to mpox or similar viruses before.
This study examines how your body's immune system remembers and responds to monkeypox infection. Researchers will analyze blood samples to understand the types of immunity you develop, which may help improve future treatments and vaccines.
This study looks at the mpox outbreak in Equateur Province, Democratic Republic of Congo. It aims to understand who gets sick and how the virus spreads, which may help with future prevention.
Hear when a new Mpox (Monkeypox) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.